X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NATCO PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NATCO PHARMA ALEMBIC LTD/
NATCO PHARMA
 
P/E (TTM) x 123.1 24.1 510.9% View Chart
P/BV x 4.6 18.3 25.1% View Chart
Dividend Yield % 0.2 0.6 39.1%  

Financials

 ALEMBIC LTD   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
NATCO PHARMA
Mar-14
ALEMBIC LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs53877 6.0%   
Low Rs29424 6.9%   
Sales per share (Unadj.) Rs4.7223.4 2.1%  
Earnings per share (Unadj.) Rs8.831.1 28.2%  
Cash flow per share (Unadj.) Rs9.040.3 22.4%  
Dividends per share (Unadj.) Rs0.155.00 3.0%  
Dividend yield (eoy) %0.40.8 47.5%  
Book value per share (Unadj.) Rs27.7219.5 12.6%  
Shares outstanding (eoy) m267.0333.07 807.5%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x8.72.9 298.9%   
Avg P/E ratio x4.720.9 22.4%  
P/CF ratio (eoy) x4.616.1 28.2%  
Price / Book Value ratio x1.53.0 50.0%  
Dividend payout %1.716.1 10.6%   
Avg Mkt Cap Rs m10,96221,504 51.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2381,128 21.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2607,389 17.1%  
Other income Rs m264167 157.9%   
Total revenues Rs m1,5247,556 20.2%   
Gross profit Rs m831,793 4.6%  
Depreciation Rs m61304 20.2%   
Interest Rs m0366 0.1%   
Profit before tax Rs m2851,290 22.1%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6309 2.0%   
Profit after tax Rs m2,3431,027 228.0%  
Gross profit margin %6.624.3 27.1%  
Effective tax rate %2.123.9 8.9%   
Net profit margin %185.913.9 1,336.9%  
BALANCE SHEET DATA
Current assets Rs m1,6893,681 45.9%   
Current liabilities Rs m4863,123 15.6%   
Net working cap to sales %95.47.6 1,262.3%  
Current ratio x3.51.2 294.6%  
Inventory Days Days21789 242.4%  
Debtors Days Days8159 138.1%  
Net fixed assets Rs m1,6247,685 21.1%   
Share capital Rs m534331 161.5%   
"Free" reserves Rs m5,9606,670 89.4%   
Net worth Rs m7,4047,259 102.0%   
Long term debt Rs m104955 10.9%   
Total assets Rs m8,01011,957 67.0%  
Interest coverage x950.74.5 21,022.6%   
Debt to equity ratio x00.1 10.7%  
Sales to assets ratio x0.20.6 25.5%   
Return on assets %29.311.7 251.0%  
Return on equity %31.614.2 223.6%  
Return on capital %31.320.7 151.0%  
Exports to sales %2.939.4 7.5%   
Imports to sales %28.95.7 506.2%   
Exports (fob) Rs m372,908 1.3%   
Imports (cif) Rs m364421 86.3%   
Fx inflow Rs m373,445 1.1%   
Fx outflow Rs m365703 51.9%   
Net fx Rs m-3282,743 -12.0%   
CASH FLOW
From Operations Rs m3461,440 24.0%  
From Investments Rs m-48-1,089 4.4%  
From Financial Activity Rs m-301-353 85.3%  
Net Cashflow Rs m-3-1 201.3%  

Share Holding

Indian Promoters % 64.0 52.0 123.0%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.2 7.8 2.6%  
FIIs % 9.7 16.6 58.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 26.0 100.4%  
Shareholders   54,701 25,395 215.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 16, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS